Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 4 3Phase 3 2Phase 2/3 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Radiation Injuries 1Neoplasms 1Dyspnea 1Breast Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Oxygen × Clear all
NCT04193722 2025-04-03

HONEY

UMC Utrecht

Phase 3 Completed
189 enrolled
Breast

Breast Neoplasms, Radiation Injuries

NCT00206609 2005-09-21

The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer

Bayside Health

Phase 3 Completed
50 enrolled
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡